Investors Are Given the Chance to Lead Capricor Therapeutics Securities Fraud Class Action with SBS Law

CAPR Investors Have a Unique Opportunity to Lead in the Capricor Therapeutics Lawsuit

In a significant turn of events, Schall, Brown & Schwartz LLP (SBS), a prominent firm specializing in shareholder rights litigation, has issued a reminder to investors regarding a potential class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR). The lawsuit centers around allegations of violations of the Securities Exchange Act of 1934, specifically concerning the company’s public disclosures and statistical analyses related to its clinical trials.

Key Details of the Lawsuit

The class action pertains to a period stretching from December 17, 2025, to July 26, 2026. During this timeframe, shareholders are encouraged to come forward if they purchased shares of Capricor. Notably, the deadline for appointing a lead plaintiff in this case is September 28, 2026. SBS reminds potential claimants that while joining the action is essential, one does not need to be designated as a lead plaintiff to seek recovery for losses suffered due to the alleged misconduct.

The Allegations

At the heart of the complaint is the claim that Capricor made several materially false and misleading statements to investors. Specifically, the company adjusted its statistical analysis plan regarding the clinical data for Deramiocel without prior approval from the FDA. This lack of compliance raised substantial concerns regarding the efficacy and potential approval of their Biologics License Application (BLA), prompting fears of an unfavorable outcome from the FDA.

As the truth emerged, revealing that the public statements made by Capricor were misleading, investors began to incur significant losses. The misrepresentation of clinical trial outcomes can undermine investor confidence and severely impact a company's market reputation.

SBS Law’s Role and Expertise

SBS Law represents individuals and entities around the globe in class action lawsuits and is committed to safeguarding shareholder rights. The firm is spearheaded by experienced attorneys Brian Schall, Andrew Brown, and David Schwartz, who are dedicated to aggressively pursuing justice for investors impacted by corporate misconduct. They invite affected investors to consult with them to discuss the possibility of participation in this class action suit without any upfront fees.

How to Get Involved

Investors who have faced financial decline due to their investment in Capricor during the class period are urged to contact SBS in order to discuss their rights and potential for recovery. Interested parties can reach out via phone or through the firm's official website for a free consultation.

Remember, filing or joining a class action lawsuit doesn’t require prior legal representation; however, getting informed about your rights as a shareholder can empower you to take necessary action.

A Call to Action

If you are among those who suffered losses from Capricor's misleading public statements, now is the time to act. Join the class action and take steps towards the recovery of your investments. It is a proactive measure that can assist not only in your individual case but may also contribute towards holding corporations accountable for their actions.

This press release also serves as a reminder that some jurisdictions consider this an attorney advertising matter, as per applicable laws and ethical rules.

For more information regarding this case or to schedule a consultation, you can contact Schall, Brown & Schwartz LLP at their Los Angeles office or visit their website.

Stay informed, stand up for your rights, and know that legal avenues exist to help mitigate the damages caused by unfair corporate practices.